Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for Amgen
Company Monitoring Page for Amgen
job ratings (see below graph) for Amgen
latest headlines for company on cafepharma
AstraZeneca snaps up Amgen site in Colorado
BioPharma Dive
Thu, 10/13/16 - 03:30 pm
Tags:
AstraZeneca
,
Amgen
,
Colorado
,
drug manufacturing
Amgen inks latest high price-tag research collaboration
BioPharma Dive
Tue, 10/4/16 - 10:14 pm
Tags:
Amgen
,
R&D
,
Nuevolution
,
oncology
,
Neuroscience
AstraZeneca hands off another Amgen-partnered drug in a $1.5B deal with an acquisitive Allergan
Endpoints
Mon, 10/3/16 - 10:09 am
Tags:
AstraZeneca
,
Amgen
,
Allergan
,
MEDI2070
,
ulcerative colitis
,
Crohn's Disease
Big Pharma vs Big Pharma in court battles over biosimilar drugs
Yahoo/Reuters
Mon, 10/3/16 - 09:58 am
Tags:
Big Pharma
,
patents
,
biosimilars
,
Novartis
,
Amgen
,
Biogen
,
Sanofi
,
Merck
,
Eli Lilly
,
Pfizer
,
JNJ
Amgen’s Backup Plan for Kyprolis (AMGN)
Investopedia
Sun, 10/2/16 - 10:22 am
Tags:
Amgen
,
Kyprolis
,
Multiple Myeloma
Amgen Maintains Migraine Drug Lead (AMGN)
Investopedia
Fri, 09/30/16 - 10:05 am
Tags:
Amgen
,
migraines
,
erenumab
Novartis, Amgen rack up their first PhIII success in a crowded CGRP migraine drug field
Endpoints
Thu, 09/29/16 - 08:23 am
Tags:
Novartis
,
Amgen
,
CGRP blockers
,
migraines
,
erenumab
Amgen and Arrowhead to develop gene-therapies for heart disease
Yahoo/Reuters
Thu, 09/29/16 - 08:18 am
Tags:
Amgen
,
Arrowhead
,
R&D
,
gene therapy
,
heart disease
FDA Approval of Amjevita Need Not Worry AbbVie Shareholders
Yahoo/GuruFocus
Thu, 09/29/16 - 08:14 am
Tags:
FDA
,
AbbVie
,
Amgen
,
biosimilars
,
Humira
,
Amjevita
Amgen's Kyprolis Fails To Met Endpoint, But It's Not All Bad News
Yahoo/Benzinga
Thu, 09/29/16 - 08:13 am
Tags:
Amgen
,
Kyprolis
,
clinical trials
,
Multiple Myeloma
Amgen's Osteoporosis Drug Crosses a Hurdle
Investopedia
Tue, 09/27/16 - 10:14 pm
Tags:
Amgen
,
osteoporosis
,
romosozumab
Amgen's multiple myeloma drug falls short in late stage study
Yahoo/Reuters
Tue, 09/27/16 - 10:18 am
Tags:
Amgen
,
Multiple Myeloma
,
Kyprolis
,
clinical trials
,
Takeda
,
Velcade
How Much Will Consumers Save on New Humira Biosimilar?
24/7 Wall St
Mon, 09/26/16 - 09:48 am
Tags:
Humira
,
biosimilars
,
Amjevita
,
AbbVie
,
Amgen
FDA approves Amgen's copy of AbbVie arthritis drug Humira
Yahoo/Reuters
Fri, 09/23/16 - 10:24 pm
Tags:
FDA
,
Amgen
,
Humira
,
rheumatoid arthritis
,
AbbVie
,
biosimilars
The drug industry might finally have an answer for migraines
Stat
Fri, 09/23/16 - 09:52 am
Tags:
migraines
,
Amgen
,
Eli Lilly
,
Alder Biopharma
,
Teva Pharmaceutical
,
CGRP blockers
Dr Reddy's and Amgen broaden marketing collaboration
BioPharma Dive
Tue, 09/20/16 - 09:51 am
Tags:
Amgen
,
Dr Reddy's
,
India
,
Xgeva
,
Prolia
,
Vectibix
Amgen Products Threatened by Court Losses
Investopedia
Mon, 09/19/16 - 03:45 pm
Tags:
Amgen
,
Apobiologix
,
Neupogen
,
Grastofil
,
Neulasta
,
Lapelga
,
biosimilars
,
patents
Amgen’s expectations for romosozumab take a hit as Radius lines up its rival osteoporosis drug
Endpoints
Mon, 09/19/16 - 09:53 am
Tags:
Amgen
,
romosozumab
,
Radius Health
,
abaloparatide
,
osteoporosis
Amgen's Biosimilar Approval And Astra's Anti-PD-L1 Data
Seeking Alpha
Sun, 09/18/16 - 09:54 am
Tags:
Amgen
,
biosimilars
,
AstraZeneca
,
anti-PD-L1
,
ABP 501
,
Humira
,
durvalumab
Gilead Sciences, Inc. a Takeover Target? It's Not as Crazy As It Sounds
Motley Fool
Mon, 09/12/16 - 09:34 am
Tags:
Gilead Sciences
,
M&A
,
JNJ
,
Novartis
,
Amgen
,
Pfizer
,
Merck
Pages
« first
‹ previous
…
37
38
39
40
41
42
43
44
45
…
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
a dog would most likely chase a: cat, rock, house
*
Fill in the blank.